Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Detrol LA Extended Release Capsules, Pharmacia and Upjohn NDA 21-228/S4 7/21/03 7/28/03 Detrol LA Capsules, 2 and 4 mg extended release, Pharmacia and Upjohn NDA 21-228/S1 4/27/01 5/1/03 Detrol LA Capsules, 2 and 4 mg extended release, Pharmacia and Upjohn NDA 21-228 12/22/00 1/9/01 1/9/01 Detrol Indications: overactive bladder with symptoms of urge urinary incontinence, urgency and frequency Detrol (Tolterodine Tartrate) Tablets, Pharmacia and Upjohn NDA 20-771/S-010 7/21/03 7/28/03 Detrol (Tolterodine Tartrate) Tablets, 1 and 2 mg, Pharmacia and Upjohn NDA 20-771/S-004 4/6/01 4/9/01 4/9/01 Detrol (Tolterodine Tartrate), 1 and 2 mg Pharmacia and Upjohn NDA 20-771 Detrol LA Extended Release Capsules, Pharmacia and Upjohn | Detrol LA (tolterodine tartrate) Tablets, Pfizer Global, Labeling Revision | Tolterodine Tartrate Tablets, Ranbaxy, Tentative Approval | Detrol (tolterodine tartrate), tablets, Pfizer, Labeling Revision | Detrol LA (tolterodine tartrate) extended release capsules, Pfizer, Efficacy Supplement w/Clinical Data | Detrol (tolterodine tartrate) Tablets, Pfizer, Labeling Revision | Detrol LA (tolterodine tartrate) Extended Release Capsules, Pfizer, Labeling Revision Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem.com